TG103
A Study of TG103 Injection in Non-diabetic Overweight or Obesity
CSPC Baike (Shandong) Biopharmaceutical Co · Phase 3 · Completed · Enrollment 675
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.